Gilead going strong at 20

06/23/2007 | San Francisco Chronicle

On Gilead Sciences' 20th anniversary, analysts said the Bay Area biotech is in a strong position to remain independent and expand into new treatment areas. Gilead, the nation's dominant seller of HIV drugs, had sales of $3 billion in 2006, and some analysts are predicting substantial growth in revenue this year.

View Full Article in:

San Francisco Chronicle

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR